What Happened?
Shares of behavioral health company Acadia Healthcare (NASDAQ: ACHC) fell 13.3% in the afternoon session after the company reported mixed second-quarter results that overshadowed beats on headline numbers.
While the company surpassed analyst expectations for revenue and adjusted earnings per share (EPS), and even slightly raised its full-year guidance, investors focused on more concerning underlying trends. Revenue was flat compared to the same quarter last year, and adjusted EPS of $0.38 was down sharply from $0.83 in the prior-year period. This significant drop in profitability signaled to investors that the company faces challenges despite outperforming muted expectations.
The negative reaction suggests the market was looking past the modest guidance increase and was more concerned with the steep year-over-year decline in earnings and stagnant sales.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Acadia Healthcare? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Acadia Healthcare’s shares are extremely volatile and have had 38 moves greater than 5% over the last year. But moves this big are rare even for Acadia Healthcare and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 6 months ago when the stock gained 24% on the news that the company announced the departure of Christopher H. Hunter and immediately reappointed former CEO Debra K. Osteen to lead. Osteen previously served as Acadia's CEO from December 2018 to March 2022. During that time, she was credited with turning the business around, which led to a near 100% increase in the stock's price. The market's strong positive reaction suggested investors were optimistic about her return. Analysts noted her successful track record as a reason for investor confidence. Adding to the news, Acadia reaffirmed its full-year 2025 financial guidance, which indicated stability in the company's underlying business outlook despite the leadership change.
Acadia Healthcare is up 97.1% since the beginning of the year, but at $28.17 per share, it is still trading 20.9% below its 52-week high of $35.61 from July 2026. Despite the year-to-date gain, investors who bought $1,000 worth of Acadia Healthcare’s shares 5 years ago would now be looking at only $456.74.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
